Condensed Consolidated Interim Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended		12 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Jun. 30, 2023
Statement of Cash Flows [Abstract]
Net Loss	$ (2,074,160)	$ (1,840,216)
Adjustments to reconcile net loss to net cash used in operations:
Depreciation	342	486
Stock based compensation	66,684	117,826
Amortization of debt issuance costs	4,862	15,201
Interest expense	127,359	81,989
Accretion expense	110,559	111,561	$ 446,245
Settlement of asset retirement obligations	(30,000)	(30,000)
Effect of changes in operating working capital items:
(Increase)/Decrease in prepaid expenses	(15,573)	397,850
Increase/(Decrease) in accounts payable	910,607	(67,403)
Cash used in operating activities	(899,320)	(1,212,706)
Cash flows from financing activities:
Capital issued for financing, net of share issuance costs	1,088,528
Cash provided by financing activities	1,088,528
Change in cash during period	189,208	(1,212,706)
Cash at beginning of period	824,920	2,484,156	2,484,156
Cash at end of period	$ 1,014,128	$ 1,271,450	$ 824,920